Cervical Non-Squamous Cell Carcinoma — Trials

Cervical Non-Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

288 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 92
Recruiting: 42
Ph III recruiting: 9
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06393751	Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer	withdrawn	Phase 1 / Phase 2	0	National Cancer Institute (NCI)NIH	0	Jun 3, 2025	clinicaltrials
NCT05295589	Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy	withdrawn	Phase 2	0	National Cancer Institute (NCI)NIH